Researchers identify new drug target for schizophrenia

August 13, 2012, The Mount Sinai Hospital

(Medical Xpress) -- Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave the way for a new class of drugs to help treat this devastating mental illness, which impacts one percent of the world's population, 30 percent of whom do not respond to currently available treatments.

A team of researchers at Mount Sinai School of Medicine set out to discover what epigenetic factors, or external factors that influence , are involved in this treatment-resistance to atypical antipsychotic drugs, the standard of care for schizophrenia. They discovered that, over time, an enzyme in the brains of schizophrenic patients analyzed at autopsy begins to compensate for the prolonged caused by antipsychotics, resulting in reduced efficacy of the drugs.

"These results are groundbreaking because they show that may be caused by the very medications prescribed to treat schizophrenia, when administered chronically," said Javier Gonzalez-Maeso, PhD, Assistant Professor of Psychiatry and Neurology at Mount Sinai School of Medicine and lead investigator on the study.

They found that an enzyme called HDAC2 was highly expressed in the brain of mice chronically treated with antipsychotic drugs, resulting in lower expression of the receptor called mGlu2, and a recurrence of . A similar finding was observed in the postmortem brains of . The research team administered a chemical called suberoylanilide hydroxamic acid (SAHA), which inhibits the entire family of HDACs. They found that this treatment prevented the detrimental effect of the antipsychotic called clozapine on mGlu2 expression, and also improved the therapeutic effects of in mouse models.

Previous research conducted by the team showed that chronic treatment with the antipsychotic clozapine causes repression of mGlu2 expression in the frontal cortex of mice, a brain area key to cognition and perception. The researchers hypothesized that this effect of clozapine on mGlu2 may play a crucial role in restraining the therapeutic effects of antipsychotic drugs.

"We had previously found that chronic antipsychotic drug administration causes biochemical changes in the brain that may limit the therapeutic effects of these drugs,"said Dr. Gonzalez-Maeso. "We wanted to identify the molecular mechanism responsible for this biochemical change, and explore it as a new target for new drugs that enhance the therapeutic efficacy of antipsychotic drugs."

Mitsumasa Kurita, PhD, a postdoctoral fellow at Mount Sinai and the lead author of the study, said, "We found that trigger an increase of HDAC2 in frontal cortex of individuals with schizophrenia, which then reduces the presence of mGlu2, and thereby limits the efficacy of these drugs," said

Dr. Gonzalez-Maeso's team is now developing compounds that specifically inhibit HDAC2 as adjunctive treatments to antipsychotics. The study was funded by the National Institutes of Health.

Explore further: Researchers develop method for advancing development of antipsychotic drugs

Related Stories

Researchers develop method for advancing development of antipsychotic drugs

November 23, 2011
Researchers interested in the treatment of schizophrenia and dementia have clarified how antipsychotic drugs that target a complex of two receptors at the surface of cells in the brain work, according to a new study published ...

Study suggests antipsychotic drugs during pregnancy linked to increased risk of gestational diabetes

July 2, 2012
A study that examined maternal use of antipsychotic drugs during pregnancy suggests that these medications may be linked to an increased risk of gestational diabetes, according to a report in the July issue of Archives of ...

Antipsychotics do help many with schizophrenia, study finds

May 3, 2012
(HealthDay) -- A new study finds that antipsychotic drugs can help many people with schizophrenia, cutting patients' risk of relapse by 60 percent.

Recommended for you

Use of electrical brain stimulation to foster creativity has sweeping implications

September 18, 2018
What is creativity, and can it be enhanced—safely—in a person who needs a boost of imagination? Georgetown experts debate the growing use of electrical devices that stimulate brain tissue, and conclude there is potential ...

Engineers decode conversations in brain's motor cortex

September 18, 2018
How does your brain talk with your arm? The body doesn't use English, or any other spoken language. Biomedical engineers are developing methods for decoding the conversation, by analyzing electrical patterns in the motor ...

Team identifies brain's lymphatic vessels as new avenue to treat multiple sclerosis

September 17, 2018
Lymphatic vessels that clean the brain of harmful material play a crucial role in the development and progression of multiple sclerosis, new research from the University of Virginia School of Medicine suggests. The vessels ...

Circuit found for brain's statistical inference about motion

September 17, 2018
As the eye tracks a bird flying past, the muscles that pan the eyeballs to keep the target in focus set their pace not only on the speed they see, but also on a reasonable estimate of the speed they expect from having watched ...

Mouse study reveals that activity, not rest, speeds recovery after brain injury

September 17, 2018
When recovering from a brain injury, getting back in the swing of things may be more effective than a prolonged period of rest, according to a new Columbia study in mice. These findings offer a compelling example of the brain's ...

Fine-tuned sense of smell relies on timing

September 17, 2018
If you can tell the difference between a merlot and a cabernet franc just by smell, it's probably all in the timing.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

tadchem
5 / 5 (1) Aug 13, 2012
Many schizophrenics develop an apparent resistance to the treatments, and increased dosage does little to help. My late brother found that after a while only ethanol would mute the interminable chatter of the internal voices. He traded his health and a large portion of his life expectancy for peace *within* his mind.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.